The Asia-Pacific fluoroscopy market was valued at USD 331.77 million in 2022. This value is estimated to be growing at a CAGR of 4.20%, to reach USD 407.55 million by 2027. The market in the rising economies of Asia-Pacific is relied upon to develop at a tremendous rate.
The fluoroscopy market in the APAC region is driven by an increase in the prevalence of chronic diseases, increased fluoroscopy usage in pain management, and a growing number of interventional radiology techniques, such as fluoroscopy, that need real-time imaging. Varicose veins, peripheral artery disease (PAD), pulmonary embolism, deep vein thrombosis, abdominal aortic aneurysms, and other prevalent medical issues are treated using this device. The market potential for fluoroscopy systems is projected to be increased by this continuous usage. To manage endovascular catheters during cardiovascular operations, considerable fluoroscopic guidance is required. Fluoroscopy has a high spatial and temporal resolution, reducing ionizing radiation exposure to patients and employees and allowing for better soft tissue characterization.
On the other hand, reimbursement cuts for analog radiography systems are expected to drive the market. Also, with a rising number of high-precision minimally invasive procedures, including the equipment utilized, the fluoroscopy market is expected to develop significantly, providing more significant support for both patients and surgeons. Due to its ability to perform effective real-time injury evaluation in athletes, hand-held fluoroscopes are gaining appeal in medical facilities and on-site situations. Fluoroscopes are expected to become more prevalent in sports medicine due to associated features such as cost-effectiveness and mobility.
Furthermore, a growing geriatric population base and an increasing incidence of orthopedic operations and angiography resulting from sports injuries are expected to be high impact rendering drivers. In addition, the Growing prevalence of minimally invasive procedures, aging population, and increasing awareness about various medical conditions in emerging countries such as India and China are propelling the market in the region. However, the rising number of hospitals across the APAC and growing demand for fluoroscopy devices drive the market.
New entrants may encounter challenges such as significant initial investment and engineering costs and the requirement for diverse product development teams. However, the side effects associated with radiation are expected to hinder the market growth over the forecast period.
This research report on the APAC Fluoroscopy Market has been segmented and sub-segmented into the following categories:
By Surgery Type:
By End User:
Geographically, the APAC fluoroscopy market is the fastest-growing regional market in the worldwide market, and it is anticipated to grow at a lucrative growth rate over the forecast period. However, the Asia Pacific market is projected to register the highest CAGR during the forecast period. The Proliferation of diseases, advancing healthcare infrastructure, and the growing number of hip and knee replacement surgeries are projected to propel the market in this region. Over the forecast period, the fluoroscopy market has recorded significant growth due to the increasing number of minimally invasive surgeries with high precision and better support for surgeons and patients. The most important aspects affecting the present state of the fluoroscopy systems market in the regional market are the rising procedure rate of orthopedic operations, cardiac diagnostic procedures, surgeries, and the growing pool of the elderly population. China, India, and Japan are the major contributors in the APAC region. The Indian fluoroscopy market is anticipated to record a better share during the forecast period and contribute to APAC regional market growth. Support by the government by providing investments and growing healthcare expenditure, and improving healthcare infrastructure is most likely to create market growth.
KEY MARKET PLAYERS:
Some of the major companies leading the APAC Fluoroscopy market profiled in this report are Philips Healthcare, GE Healthcare, Siemens Medical Solutions, Shimadzu Medical Systems, Shanghai Bojin Medical Instrument Co., Ltd, and Toshiba Medical Systems Corp.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org